Medicare Enrolled

Dr. Michael Schwartz, M.D.

Optician · Miami Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4306 ALTON RD, Miami Beach, FL 33140
3055353337
In practice since 2005 (20 years)
NPI: 1972591683 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwartz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwartz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwartz

Dr. Michael Schwartz is an optician in Miami Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Schwartz performed 762 Medicare services across 359 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schwartz received a total of $28,730 from 93 pharmaceutical and/or device companies across 1589 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwartz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 762 Medicare services$ $28,730 industry payments

Medicare Practice Summary

Medicare Utilization ↗
762
Medicare services
Bottom 36% in FL for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
359
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~38 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)434$52$165
Hospital follow-up visit, moderate complexity118$67$228
Office visit, established patient (30-39 min)112$78$252
Initial hospital admission, moderate complexity61$107$449
New patient office visit (45-59 min)24$108$433
Biopsy and aspiration of bone marrow sample for diagnosis13$61$262
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$28,730
Total received (2018-2024)
Avg $4,104/year across 7 years
Top 6% in FL for optician
93
Companies
1,589
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,333 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$397 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,216
2023
$4,408
2022
$3,267
2021
$3,431
2020
$3,347
2019
$4,452
2018
$4,609

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,371
Celgene Corporation
$1,802
Novartis Pharmaceuticals Corporation
$1,772
Genentech USA, Inc.
$1,722
PFIZER INC.
$1,597
Janssen Biotech, Inc.
$1,444
Merck Sharp & Dohme Corporation
$1,269
E.R. Squibb & Sons, L.L.C.
$1,186
Incyte Corporation
$1,077
Daiichi Sankyo Inc.
$961
Astellas Pharma US Inc
$864
Amgen Inc.
$603
GENZYME CORPORATION
$567
Seagen Inc.
$550
GlaxoSmithKline, LLC.
$487
Merck Sharp & Dohme LLC
$485
Exelixis Inc.
$464
Lilly USA, LLC
$461
Pharmacyclics LLC, An AbbVie Company
$421
Regeneron Healthcare Solutions, Inc.
$353
Takeda Pharmaceuticals U.S.A., Inc.
$325
Janssen Pharmaceuticals, Inc
$318
Bayer HealthCare Pharmaceuticals Inc.
$248
Gilead Sciences, Inc.
$245
ABBVIE INC.
$243
AVEO Pharmaceuticals, Inc.
$233
ARRAY BIOPHARMA INC
$232
Rigel Pharmaceuticals, Inc.
$227
Kite Pharma, Inc.
$223
EMD Serono, Inc.
$213
Pharmacosmos Therapeutics Inc.
$203
Eisai Inc.
$203
Myriad Genetic Laboratories, Inc.
$196
Deciphera Pharmaceuticals Inc.
$185
Epizyme, Inc.,
$181
Clovis Oncology, Inc.
$178
SERVIER PHARMACEUTICALS LLC
$170
Sumitomo Pharma America, Inc.
$169
Pharmacyclics LLC, an AbbVie Company
$165
Mirati Therapeutics, Inc.
$161
Array BioPharma Inc.
$161
AbbVie Inc.
$155
Janssen Scientific Affairs, LLC
$152
SpringWorks Therapeutics, Inc.
$146
Myovant Sciences Inc.
$138
EISAI INC.
$138
Seattle Genetics, Inc.
$132
TESARO, Inc.
$128
Adaptive Biotechnologies Corporation
$128
Foundation Medicine, Inc.
$127
EUSA Pharma (US) LLC
$124
Taiho Oncology, Inc.
$119
Kyowa Kirin, Inc.
$113
TerSera Therapeutics LLC
$110
MorphoSys, US Inc.
$110
AbbVie, Inc.
$105
TAIHO ONCOLOGY, INC.
$103
BeiGene USA, Inc.
$101
Ipsen Biopharmaceuticals, Inc
$95
Blueprint Medicines Corporation
$94
SOBI, INC
$92
Stemline Therapeutics Inc.
$87
Helsinn Therapeutics (U.S.), Inc.
$87
Karyopharm Therapeutics Inc.
$85
Alexion Pharmaceuticals, Inc.
$84
Teva Pharmaceuticals USA, Inc.
$77
Dova Pharmaceuticals
$76
ADC Therapeutics America, Inc.
$76
Janssen Products, LP
$65
MEDIVATION FIELD SOLUTIONS LLC
$65
G1 Therapeutics, Inc.
$60
Acceleron Pharma, Inc.
$55
Verastem, Inc.
$52
CTI BioPharma Corp.
$52
Agios Pharmaceuticals, Inc.
$50
Dendreon Pharmaceuticals LLC
$44
AMAG Pharmaceuticals, Inc.
$39
Aveo Pharmaceuticals, Inc.
$35
JAZZ PHARMACEUTICALS INC.
$33
PUMA BIOTECHNOLOGY, INC.
$30
Shire North American Group Inc
$29
Jazz Pharmaceuticals Inc.
$25
Genmab U.S., Inc.
$24
Sun Pharmaceutical Industries Inc.
$22
Fennec Pharmaceuticals, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Medtronic USA, Inc.
$15
Apellis Pharmaceuticals, Inc.
$15
Aurobindo Pharma USA, Inc.
$15
Tempus AI, Inc
$14
RECORDATI_RARE_DISEASES_INC.
$14
Advanced Accelerator Applications
$14
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 20.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKEEGA · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Neulasta · Nexavar · Non-Covered Product · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · QUZYTTIR · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SARCLISA · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNCHROMED · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for optician in FL.

Equivalent to $3,770 per 100 Medicare services performed
Looking for a optician in Miami Beach?
Compare opticians in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
711
Per 100K population
26.5
County median income
$68,694
Nearest hospital
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Schwartz is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 6%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Schwartz experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Schwartz performed 434 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwartz receive payments from pharmaceutical companies?
Yes. Dr. Schwartz received a total of $28,730 from 93 companies across 1,589 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwartz's costs compare to other opticians in Miami Beach?
Dr. Schwartz's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwartz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →